• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY CAROTID WALLSTENT MONORAIL; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY CAROTID WALLSTENT MONORAIL; STENT, CAROTID Back to Search Results
Model Number UNK60
Device Problem Occlusion Within Device (1423)
Patient Problem Thrombosis (2100)
Event Date 10/29/2013
Event Type  Injury  
Event Description
It was reported that stent thrombosis occurred.On (b)(6) 2013, carotid wallstent deployment was performed with a non-bsc proximal cerebral protection system.It was 55% stenosed lesion from right internal carotid artery to common carotid artery.After blocking the flow of blood with the non-bsc cerebral protection system, the stent was deployed without performing pre-dilatation.Post-dilatation was performed at the site with an unspecified balloon catheter where the stent was deployed and the procedure was completed successfully.The lesion resulted in 0% stenosis.Time of blood flow blockage by the cerebral protection system was not measured.Bayaspirin, clopidogrel and pletaal were administered as pretreatment and combination treatment.Also, filter wire ez was concomitantly used as the protection device during stent deployment, post-dilatation and aspiration of blood clot, since oxygen desaturation was confirmed regionally during procedure.There were no changes on preoperative and postoperative clinical course, and the health damage to the patient was not confirmed.On the 5th day after the procedure, in-stent thrombosis was confirmed by the echo in carotid.Echo revealed 1.7mm defect.On (b)(6) 2013, the defect was found to be bigger.It was confirmed that the stenosis rate in the carotid artery was 60% based on (b)(6).Emergency pta was performed.The patients status was stable.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT MONORAIL
Type of Device
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4033783
MDR Text Key17694713
Report Number2134265-2014-05043
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
PMA/PMN Number
P050019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/30/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK60
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/30/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDEWIRE: FILTERWIRE EZ
Patient Outcome(s) Required Intervention;
-
-